Economic cost of primary prevention of cardiovascular diseases in Tanzania

Health Policy and Planning

Volumn 30, Issue 7, 2015, Pages 875-884

  Ngalesoni, Frida ^a,b   Ruhago, George ^b,c   Norheim, Ole F ^b   Robberstad, Bjarne ^b  

^a MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^b UNIVERSITY OF BERGEN   (Norway)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Cardiovascular disease; Cost analysis; Diabetes; Direct and indirect cost; Hypertension; Primary prevention; Sub Saharan Africa; Tanzania

Indexed keywords

CARDIOVASCULAR DISEASES; COST; ECONOMICS; HUMAN; HYPERTENSION; PRIMARY PREVENTION; TANZANIA;

CARDIOVASCULAR DISEASES; COSTS AND COST ANALYSIS; HUMANS; HYPERTENSION; PRIMARY PREVENTION; TANZANIA;

EID: 84941924382     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czu088     Document Type: Article

References (56)

1. Aspray TJ, Mugusi F, Rashid S et al. 2000. Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Transactions of the Royal Society of Tropical Medicine and Hygiene 94: 637-44.
2. Association of Physicians of Tanzania. 2003. Guidelines for the Management of Hypertension. Dar es Salaam: Association of Physicians of Tanzania.
3. Bank of Tanzania. 2012a. Financial Markets; Interbank Foreign ExchangeMarket (IFEM) Summaries. http://www.bot-tz.org/FinancialMarkets/IFEMsummaries/IFEMsummaries.asp, accessed September 2012.
4. Bank of Tanzania. 2012b. Interest Rate Structure. http://www.bot-tz.org/Publications/InterestRates.htm, accessed September 2012.
5. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S. 2011. TheGlobal Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.
6. Bovet P, Gervasoni JP, Mkamba M et al. 2008. Low utilization of health care services following screening for hypertension in Dar es Salaam (Tanzania): a prospective population-based study. BMC Public Health 8: 407.
7. Bovet P, Ross AG, Gervasoni JP et al. 2002. Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salaam, Tanzania, and associations with socioeconomic status. International Journal of Epidemiology 31: 240-7.
8. Campbell MJ. 2008. Statistics at Square Two: Understanding Modern Statistical Applications in Medicine, JohnWiley & Sons.
9. Connor MD, Walker R, Modi G, Warlow CP. 2007. Burden of stroke in black populations in sub-Saharan Africa. Lancet Neurology 6: 269-78.
10. Conteh L, Walker D. 2004. Cost and unit cost calculations using stepdown accounting. Health Policy and Planning 19: 127-35.
11. Dalal S, Beunza JJ, Volmink J et al. 2011. Non-communicable diseases in sub-Saharan Africa: what we know now. International Journal of Epidemiology 40: 885-901.
12. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. 2005. Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press, Oxford.
13. Edwards R, Unwin N, Mugusi F et al. 2000. Hypertension prevalence and care in an urban and rural area of Tanzania. Journal of Hypertension 18: 145-52.
14. Ensor T, Cooper S. 2004. Overcoming barriers to health service access: influencing the demand side. Health Policy and Planning 19: 69-79.
15. Fleßa S. 2009. Costing of Health Care Services in Developing Countries: A Prerequisite for Affordability, Sustainability and Efficiency. Lang: Frankfurt am Main.
16. Gaziano T. 2008. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart 94: 140-4.
17. Gaziano TA. 2007. Reducing the growing burden of cardiovascular disease in the developing world. Health Affairs 26: 13-24.
18. Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. 2005. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation 112: 3569-76.
19. Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S. 2009. A sub-Saharan African perspective of diabetes. Diabetologia 52: 8-16.
20. Gold MR, Siegel JE, Russell LB, Weinstein MC. 1996. Cost-Effectiveness in Health and Medicine. Oxford University Press, Oxford.
21. Grossman E, Messerli FH. 2011. Management of blood pressure in patients with diabetes. American Journal of Hypertension 24: 863-75.
22. Hall V, Thomsen RW, Henriksen O, Lohse N. 2011. Diabetes in sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 11: 564.
23. Harpham T, Molyneux C. 2001. Urban health in developing countries: a review. Progress in Development Studies 1: 113-37.
24. Hendriks ME, Wit FW, Roos MT et al. 2012. Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. PloS One 7: e32638.
25. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. 2005. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. The Lancet 365: 434-41.
26. Klemick H, Leonard KL, Masatu MC. 2009. Defining access to health care: evidence on the importance of quality and distance in rural Tanzania. American Journal of Agricultural Economics 91: 347-58.
27. Lemogoum D, Seedat YK, Mabadeje AF et al. 2003. Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa. Journal of Hypertension 21: 1993-2000.
28. Maluka SO, Hurtig AK, Sebastián MS et al. 2011. Decentralization and health care prioritization process in Tanzania: from national rhetoric to local reality. The International Journal of Health Planning and Management 26: e102-20.
29. Management Science for Health. 2012. International Drug Price Indicator Guide, 2012. Arlington, TX: Management Science for Health.
30. Mathers C, Fat DM, Boerma JT. 2008. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization.
31. Mbanya JC, Mbanya D. 2003. Diabetes cost in sub-Saharan Africa. Journal of Cardiovascular Risk 10: 191-3.
32. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. 2010. Diabetes in sub-Saharan Africa. The Lancet 375: 2254-66.
33. Medical Stores Department, Tanzania. 2011\2012. Price Catalogue of Essential Medicines, Diagnostics and Hospital Supplies.
34. Mendis S, Abegunde D, Oladapo O, Celletti F, Nordet P. 2004. Barriers to management of cardiovascular risk in a low-resource setting using hypertension as an entry point. Journal of Hypertension 22: 59-64.
35. Mensah GA. 2008. Ischemic heart disease in Africa. Heart 94: 836-43.
36. Ministry of Health and Social Welfare. 2000. National Package of Essential Health Interventions. Dar es Salaam: Ministry of Health and Social Welfare.
37. Ministry of Health and Social Welfare. 2008. Health Sector Strategic Plan III: "Partnerships for Delivering the MDGs" July 2009-June 2015. Dar es Salaam: Ministry of Health and Social Welfare.
38. Mogyorosy Z, Smith P. 2005. The main methodological issues in costing health care services: a literature review. CHE Research Paper 7.
39. Mori AT, Kaale EA, Ngalesoni F, Norheim OF, Robberstad B. 2013. The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. PloS one, 9, e84824.
40. Msuya J. 2003. Horizontal and Vertical Delivery of Health Services: What Are the Tradeoffs. Washington, DC: World Bank. http://documents.worldbank.org/curated/en/2003/01/2593723/horizontalvertical-delivery-health-services-trade-offs# accessed June 2013.
41. Munga M, Mæstad O. 2009. Measuring inequalities in the distribution of health workers: the case of Tanzania. Human Resources for Health 7: 4.
42. Munga MA, Songstad NG, Blystad A, Mæstad O. 2009. The decentralisation-centralisation dilemma: recruitment and distribution of health workers in remote districts of Tanzania. BMC International Health and Human Rights 9: 9.
43. Murray CJ, Vos T, Lozano R et al. 2012. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380: 2197-223.
44. National Bureau of Statistics. 2011. National Accounts of Tanzania Mainland 2000-2010. Dar es Salaam: National Bureau of Statistics.
45. Njelekela MA, Mpembeni R, Muhihi A et al. 2009. Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania. BMC Cardiovascular Disorders 9: 30.
46. Njelekela M, Negishi H, Nara Y et al. 2001. Cardiovascular risk factors in Tanzania: a revisit. Acta Tropica 79: 231-9.
47. Peters DH, Garg A, Bloom G et al. 2008. Poverty and access to health care in developing countries. Annals of the New York Academy of Sciences 1136: 161-71.
48. Reddy KS. 2004. Cardiovascular disease in non-Western countries. New England Journal of Medicine 350: 2438-510.
49. Sanderson JE, Mayosi B, Yusuf S et al. 2007. Global burden of cardiovascular disease. Heart 93: 1175.
50. Twagirumukiza M, De Bacquer D, Kips JG et al. 2011. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. Journal of Hypertension 29: 1243-52.
51. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2000. Costing Guidelines for HIV Prevention Strategies. Geneva: UNAIDS.
52. UNAIDS. 2011. Manual for Costing HIV Facilities and Services. Geneva: UNAIDS.
53. WHO. 2007. Prevention of Cardiovascular Disease: Guidelines for Assessmentand Management of Cardiovascular Risk. Geneva: WHO.
54. WHO. 2012a. CHOosing Interventions that are Cost Effective (WHO-CHOICE). http://www.who.int/choice/costs/useful-life/en/index.html, accessed September 2012.
55. WHO. 2012b. Prevention and Control of Non-Communicable Diseases: Guidelines for Primary Health Care in Low-Resource Settings. Geneva: WHO.
56. Wright JM, Musini VM. 2009. First-line drugs for hypertension. Cochrane Database of Systematic Reviews. CD001841.